The radioactive tracer market comprises radioactive materials or radiopharmaceuticals that emit gamma rays or positrons. These radioactive tracers are used in diagnostic imaging procedures such as positron emission tomography (PET) scans and single-photon emission computed tomography (SPECT) scans. They help doctors and specialists gain functional information about tissues, joints, and other internal organs and detect abnormalities such as cancer.
The global radioactive tracer market is estimated to be valued at US$ 2.28 billion in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2031 Key Takeaways Key players operating in the radioactive tracer market are Signify, Eaton, Hubbell Lighting, Acuity Brands, Osram, Leviton, Cree, GE Lighting, Philips Lighting, and Honeywell. The Radioactive Tracer Market Growth tracers is attributed to the increasing use of SPECT and PET scans for advanced diagnostics in disease conditions such as cancer, cardiac ailments, and neurological disorders. Furthermore, the rising geriatric population prone to chronic diseases is also fueling the demand. Globally, the market is witnessing expansion in developing regions due to improving healthcare infrastructure and increasing awareness. The abundant availability of government and private funding for nuclear medicine research is also a key factor boosting the radioactive tracer market. Market Key Trends One of the key trends in the Radioactive Tracer Market Size and Trends is the rising demand for cyclotron-produced radiotracers. A cyclotron is a particle accelerator device used to produce short-lived radioactive isotopes used as tracers in nuclear medicine imaging. The growing need for cyclotron-produced radiotracers is due to their ability to customize doses, improve half-lives, and reduce costs of production compared to reactor-produced tracers. With continual technological advancements, cyclotron technology is enabling efficient production of customized radiotracers and greater access. This trend is positively impacting the radioactive tracer industry.
Porter’s Analysis Threat of new entrants: Low costs of entry for new suppliers of stable isotopes and production equipment. Bargaining power of buyers: Large pharmaceutical companies and research institutions hold significant bargaining power. Bargaining power of suppliers: Suppliers of radioisotopes and high-tech equipment hold some bargaining power given specialized production process. Threat of new substitutes: Limited threat as radioisotopes are uniquely suited for diagnostic purposes and medical imaging. Competitive rivalry: Intense competition among major players to develop new tracers for disease diagnosis and drug development. Geographical regions North America currently dominates the radioactive tracer market in terms of value share. This is attributed to substantial funding for nuclear medicine research and a rising geriatric population undergoing diagnostic scans. The Asia Pacific region is expected to be the fastest growing market for radioactive tracers through 2031. Increased healthcare expenditures, growing diagnostic volumes, and expanding nuclear medicine infrastructure across China, India, and other Asian nations are driving market growth. Countries are working to ensure stable supplies of critical medical radioisotopes.
For More Insights Discover the Report In language that Resonates with you
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
